Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/52376
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Russell, Darryl L. | en_US |
dc.contributor.author | Doyle, K. M H | en_US |
dc.contributor.author | Gonzales-Robayna, Ignacio | en_US |
dc.contributor.author | Pipaon, Carlos | en_US |
dc.contributor.author | Richards, Joanne S. | en_US |
dc.date.accessioned | 2018-11-25T19:48:47Z | - |
dc.date.available | 2018-11-25T19:48:47Z | - |
dc.date.issued | 2003 | en_US |
dc.identifier.issn | 0888-8809 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/52376 | - |
dc.description.abstract | Early growth response factor (Egr-1) is an inducible zinc finger transcription factor that binds specific GC-rich enhancer elements and impacts female reproduction. These studies document for the first time that FSH rapidly induces Egr-1 expression in granulosa cells of small growing follicles. This response is transient but is reinitiated in preovulatory follicles exposed to the LH analog, human chorionic gonadotropin. Immunohistochemical analysis also showed gonadotropin induced Egr-1 in theca cells. The Egr-1 gene regulatory region responsive to gonadotropin signaling was localized within -164 bp of the transcription initiation site. Binding of Sp1/Sp3 to a proximal GC-box at -64/-46 bp was enhanced by FSH in immature granulosa cells but reduced after human chorionic gonadotropin stimulation of preovulatory follicles despite constant protein expression. This dynamic regulation of Sp1 binding was dependent on gonadotropin-regulated mechanisms that modulate Sp1/3-DNA binding activity. Serum response factor was active in granulosa cells and bound a consensus CArG-box/serum response element site, whereas two putative cAMP response elements within the -164-bp region bound cAMP regulatory element (CRE) binding protein (CREB) and a second cAMP-inducible protein immunologically related to CREB. Transient transfection analyses using Egr-1 promoter-luciferase constructs and site-specific mutations show that the serum response element, GC-box, and CRE-131 are involved in gonadotropin regulation of Egr-1 expression in granulosa cells. Specific kinase inhibitors of Erk or protein kinase A antagonized this induction while exogenously expressed Egr-1 enhanced reporter expression. These observations indicate that the Egr-1 gene is a target of both FSH and LH action that may mediate molecular programs of proliferation and/or differentiation during follicle growth, ovulation, and luteinization. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Molecular Endocrinology | en_US |
dc.source | Molecular Endocrinology[ISSN 0888-8809],v. 17(4), p. 520-533 (Abril 2003) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320502 Endocrinología | en_US |
dc.subject | 2401 Biología animal (zoología) | en_US |
dc.subject.other | Granulosa cells | en_US |
dc.subject.other | Luteinizing hormone | en_US |
dc.subject.other | Adenosine | en_US |
dc.subject.other | Monophosphate | en_US |
dc.subject.other | Serum | en_US |
dc.title | Egr-1 induction in rat granulosa cells by follicle-stimulating hormone and luteinizing hormone: Combinatorial regulation by transcription factors cyclic adenosine 3′,5′-monophosphate regulatory element binding protein, serum response factor, Sp1, and early growth response factor-1 | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1210/me.2002-0066 | en_US |
dc.identifier.scopus | 0037384070 | - |
dc.contributor.authorscopusid | 7403670173 | - |
dc.contributor.authorscopusid | 36906890700 | - |
dc.contributor.authorscopusid | 8738000400 | - |
dc.contributor.authorscopusid | 6507425244 | - |
dc.contributor.authorscopusid | 6603219168 | - |
dc.contributor.authorscopusid | 56831435300 | - |
dc.contributor.authorscopusid | 7403707010 | - |
dc.description.lastpage | 533 | en_US |
dc.identifier.issue | 4 | - |
dc.description.firstpage | 520 | en_US |
dc.relation.volume | 17 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.description.numberofpages | 14 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Abril 2003 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.jcr | 5,708 | - |
dc.description.jcrq | Q1 | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.orcid | 0000-0002-7650-4454 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | González Robayna, Ignacio Javier | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
91
checked on Nov 17, 2024
WEB OF SCIENCETM
Citations
85
checked on Nov 17, 2024
Page view(s)
49
checked on Feb 17, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.